Stockholm, February 10, 2015 — Nasdaq (Nasdaq: NDAQ) announces that the trading in Karessa Pharma Holding AB’s shares (shortname: KARE) commenced today on First North at Nasdaq Stockholm. Karessa Pharma belongs to the Health Care sector and is (including switches) the sixth company to be admitted to trading on Nasdaq’s Nordic markets* in 2015.
Karessa Pharma is developing and commercialising the next generation of medicinal products to treat erectile dysfunction. Karessa Pharma's concept is based on a patented drug delivery film, which is combined with clinically tested and proven active substances. This combination results in a medicinal product that delivers both a direct and reliable effect. For more information, please visit www.karessa.se.
“This listing is a natural step in our endeavour to establish Karessa Pharma as a leading, innovative company on the growing market for drugs treating erectile dysfunction,” said Torbjörn Kemper, CEO of Karessa Pharma. “The problem is widespread, the market is enormous, and we will be able to contribute with a better solution than those that are currently available.”
“We welcome Karessa Pharma to First North and to our Nasdaq-family of companies,” said Adam Kostyál, senior vice president and head of European listings at Nasdaq. “We continue to see a strong interest for the public markets within the life science sector and today’s listing underlines that trend.”
Karessa Pharma has appointed Remium Nordic AB as Certified Adviser.
*Main markets and First North at Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland and Nasdaq Stockholm.
About First North
First North is regulated as a multilateral trading facility, operated by the different exchanges within Nasdaq Nordic (First North Denmark is regulated as an alternative marketplace). It does not have the legal status as an EU-regulated market. Companies at First North are subject to the rules of First North and not the legal requirements for admission to trading on a regulated market. The risk in such an investment may be higher than on the main market”
Nasdaq (Nasdaq:NDAQ) is a leading provider of trading, clearing, exchange technology, regulatory, securities listing, information and public company services across six continents. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 70 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to more than 3,500 listed companies with a market value of over $9.1 trillion and more than 10,000 corporate clients. To learn more, visit www.nasdaq.com/ambition or www.nasdaqomx.com.
Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland, Nasdaq Riga, Nasdaq Stockholm, Nasdaq Tallinn, Nasdaq Vilnius, Nasdaq Clearing and Nasdaq Broker Services are respectively brand names for the regulated markets of Nasdaq OMX Copenhagen A/S, Nasdaq OMX Helsinki Ltd., Nasdaq OMX Iceland hf., Nasdaq OMX Riga, AS, Nasdaq OMX Stockholm AB, Nasdaq OMX Tallinn AS, AB Nasdaq OMX Vilnius, Nasdaq OMX Clearing AB, Nasdaq OMX Broker Services AB. Nasdaq Nordic represents the common offering by Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland and Nasdaq Stockholm. Nasdaq Baltic represents the common offering by Nasdaq Tallinn, Nasdaq Riga and Nasdaq Vilnius.
Cautionary Note Regarding Forward-Looking Statements
The matters described herein contain forward-looking statements that are made under the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements about Nasdaq and its products and offerings. We caution that these statements are not guarantees of future performance. Actual results may differ materially from those expressed or implied in the forward-looking statements. Forward-looking statements involve a number of risks, uncertainties or other factors beyond Nasdaq's control. These factors include, but are not limited to factors detailed in Nasdaq's annual report on Form 10-K, and periodic reports filed with the U.S. Securities and Exchange Commission. We undertake no obligation to release any revisions to any forward-looking statements.
Media Relations Contact:
+46 8 405 6639
Nasdaq Press Center
Read the latest press releases, request a press kit, and get in touch with our press team.